CSF1R-IN-2 is a potent, orally bioavailable small molecule inhibitor targeting SRC, MET, and c-FMS (CSF1R) kinases with sub-nanomolar IC50 values. It serves as a valuable research tool for investigating tumor proliferation, metastasis, and tumor-associated macrophage biology in both cellular and animal models of cancer and inflammatory diseases.